Human albumin administration in critically ill patients

Intensive Care Medicine

Volumn 25, Issue 3, 1999, Pages 323-325

  Ferguson, N D ^a   Stewart, T E ^a,b   Etchells, E E ^a  

^a Critical Care Medicine Programme   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN ALBUMIN;

BRAIN ISCHEMIA; CLINICAL TRIAL; CRITICAL ILLNESS; DATA ANALYSIS; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NEPHROTIC SYNDROME; SHORT SURVEY; THERMAL INJURY; TREATMENT OUTCOME;

CRITICAL ILLNESS; HUMANS; PLASMA SUBSTITUTES; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SERUM ALBUMIN;

EID: 0033024012     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050844     Document Type: Short Survey

References (7)

1. 1. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA (1995) A paradigm for consensus. The University Hospital Consortium Guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 155:373-379
2. 2. Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316: 961-964
3. 3. Oxman AD, Cook DJ, Guyatt GH (1994) Users' guide to the medical literature. VI. How to use an overview. JAMA 272: 1367-1371
4. 4. Oxman AD (1993) Meta-statistics: help or hindrance? ACP Journal Club May/ June:A-13-A-15
5. 5. Pogue J, Yusuf S (1998) Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 351: 47-52
6. 6. Yim JM, Vermeulen LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH (1995) Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med 155: 2450-2455
7. 7. Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317: 235-240